Correlation Between Tempest Therapeutics and Spyre Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and Spyre Therapeutics, you can compare the effects of market volatilities on Tempest Therapeutics and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and Spyre Therapeutics.

Diversification Opportunities for Tempest Therapeutics and Spyre Therapeutics

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between Tempest and Spyre is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and Spyre Therapeutics go up and down completely randomly.

Pair Corralation between Tempest Therapeutics and Spyre Therapeutics

Given the investment horizon of 90 days Tempest Therapeutics is expected to generate 1.16 times more return on investment than Spyre Therapeutics. However, Tempest Therapeutics is 1.16 times more volatile than Spyre Therapeutics. It trades about -0.12 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.19 per unit of risk. If you would invest  110.00  in Tempest Therapeutics on August 30, 2024 and sell it today you would lose (16.00) from holding Tempest Therapeutics or give up 14.55% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Tempest Therapeutics  vs.  Spyre Therapeutics

 Performance 
       Timeline  
Tempest Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tempest Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Spyre Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Spyre Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Tempest Therapeutics and Spyre Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tempest Therapeutics and Spyre Therapeutics

The main advantage of trading using opposite Tempest Therapeutics and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.
The idea behind Tempest Therapeutics and Spyre Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years